Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

Mazeh D, Shahal B, Aviv A, Zemishlani H, Barak Y.

Int Clin Psychopharmacol. 2007 Nov;22(6):371-5.

PMID:
17917556
2.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
3.

Clinical evaluation of venlafaxine.

Ballenger JC.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. Review.

PMID:
8784646
4.

The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database.

Rudolph RL, Derivan AT.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):54S-59S; discussion 59S-61S. Review.

PMID:
8784648
5.

[Therapeutic action lag time and resistance to treatment].

Peretti CS.

Encephale. 1999 Jun;25 Spec No 2:49-54. Review. French.

PMID:
10434159
6.

Dose-response relationship with venlafaxine.

Kelsey JE.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):21S-26S; discussion 26S-28S. Review.

PMID:
8784645
7.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
8.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
9.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

10.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
11.

Venlafaxine: a 2003 update.

Gutierrez MA, Stimmel GL, Aiso JY.

Clin Ther. 2003 Aug;25(8):2138-54. Review.

PMID:
14512125
12.

[Severe forms of depression: the efficacy of escitalopram].

Spadone C.

Encephale. 2009 Apr;35(2):152-9. doi: 10.1016/j.encep.2008.09.008. Epub 2009 Mar 31. Review. French.

PMID:
19393384
14.

Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.

Mukai Y, Tampi RR.

Clin Ther. 2009 May;31(5):945-61. doi: 10.1016/j.clinthera.2009.05.016. Review.

PMID:
19539096
15.

Pharmacologic profile and efficacy of venlafaxine.

Mendlewicz J.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:5-13. Review.

PMID:
7622816
16.

Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.

Thase ME, Trivedi M.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:93-102. Review.

PMID:
12490825
17.

Cardiovascular safety in depressed patients: focus on venlafaxine.

Feighner JP.

J Clin Psychiatry. 1995 Dec;56(12):574-9. Review.

PMID:
8530334
18.

Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.

Maneeton N, Maneeton B, Eurviriyanukul K, Srisurapanont M.

Drug Des Devel Ther. 2013 Sep 27;7:1053-62. doi: 10.2147/DDDT.S46849. eCollection 2013. Review.

19.

Safety and tolerance profile of venlafaxine.

Danjou P, Hackett D.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:15-20. Review.

PMID:
7622813
20.

Efficacy of venlafaxine in geriatric depression.

Staab JP, Evans DL.

Depress Anxiety. 2000;12 Suppl 1:63-8. Review.

PMID:
11098416

Supplemental Content

Support Center